Patent 10105436 was granted and assigned to Calidi Biotherapeutics on October, 2018 by the United States Patent and Trademark Office.
Disclosed herein are methods and compositions related to therapy for cancer. More specifically, the disclosed methods and compositions are related to the use of smallpox vaccine to induce an effective anti-tumor immune response.